Compare ORIC & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORIC | CGNT |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.0M | 704.1M |
| IPO Year | 2020 | N/A |
| Metric | ORIC | CGNT |
|---|---|---|
| Price | $8.15 | $8.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $19.50 | $14.00 |
| AVG Volume (30 Days) | ★ 1.4M | 291.4K |
| Earning Date | 02-17-2026 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $388,304,000.00 |
| Revenue This Year | N/A | $16.36 |
| Revenue Next Year | N/A | $10.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.27 |
| 52 Week Low | $3.90 | $7.64 |
| 52 Week High | $14.93 | $11.66 |
| Indicator | ORIC | CGNT |
|---|---|---|
| Relative Strength Index (RSI) | 28.24 | 43.85 |
| Support Level | $7.96 | $9.17 |
| Resistance Level | $8.44 | $9.86 |
| Average True Range (ATR) | 0.42 | 0.26 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 10.92 | 4.36 |
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.